{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:25:46Z","timestamp":1787934346282,"version":"build-2784847793"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.bcp.2020.114142","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T23:09:07Z","timestamp":1594336147000},"page":"114142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Type 2 diabetes mellitus decreases systemic exposure of clopidogrel active metabolite through upregulation of P-glycoprotein in rats"],"prefix":"10.1016","volume":"180","author":[{"given":"Hongwei","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingkai","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yani","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bcp.2020.114142_b0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1515\/dmdi.2011.002","article-title":"Clopidogrel pharmacogenetics: metabolism and drug interactions","volume":"26","author":"Close","year":"2011","journal-title":"Drug Metabol. Drug Interact."},{"issue":"3","key":"10.1016\/j.bcp.2020.114142_b0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2796.2002.01027.x","article-title":"Individual variations of platelet inhibition after loading doses of clopidogrel","volume":"252","author":"Jaremo","year":"2002","journal-title":"J. Intern. Med."},{"issue":"5","key":"10.1016\/j.bcp.2020.114142_b0015","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1055\/s-0037-1613462","article-title":"Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement","volume":"89","author":"Muller","year":"2003","journal-title":"Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.bcp.2020.114142_b0020","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jacc.2014.06.1170","article-title":"Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease","volume":"64","author":"Angiolillo","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.bcp.2020.114142_b0025","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.atherosclerosis.2011.03.039","article-title":"Impaired inhibition of P2Y(12) by clopidogrel is a major determinant of cardiac death in diabetes mellitus patients treated by percutaneous coronary intervention","volume":"217","author":"El Ghannudi","year":"2011","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.bcp.2020.114142_b0030","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0037-1614133","article-title":"Identification and biological activity of the active metabolite of clopidogrel","volume":"84","author":"Savi","year":"2000","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcp.2020.114142_b0035","doi-asserted-by":"crossref","unstructured":"J.T. Brandt C.D. Payne S.D. Wiviott G. Weerakkody N.A. Farid D.S. Small J.A. Jakubowski H. Naganuma K.J. Winters A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation Am Heart J 153 1 2007 pp. 66\u2013e9\u201316.","DOI":"10.1016\/j.ahj.2006.10.010"},{"issue":"5","key":"10.1016\/j.bcp.2020.114142_b0040","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.clpt.2006.07.007","article-title":"Impact of P-glycoprotein on clopidogrel absorption","volume":"80","author":"Taubert","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2020.114142_b0045","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/dmd.109.029132","article-title":"Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite","volume":"38","author":"Kazui","year":"2010","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.bcp.2020.114142_b0050","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/03602532.2018.1497645","article-title":"Alterations of drug-metabolizing enzymes and transporters under diabetic conditions: what is the potential clinical significance?","volume":"50","author":"Chen","year":"2018","journal-title":"Drug. Metab. Rev."},{"issue":"10","key":"10.1016\/j.bcp.2020.114142_b0055","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1021\/mp500330y","article-title":"Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine","volume":"11","author":"Drozdzik","year":"2014","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.bcp.2020.114142_b0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejps.2005.05.004","article-title":"Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formation","volume":"26","author":"Kim","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.bcp.2020.114142_b0065","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/aps.2014.39","article-title":"Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes","volume":"35","author":"Xu","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"10.1016\/j.bcp.2020.114142_b0070","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1124\/dmd.118.085126","article-title":"Enhanced Platelet Response to Clopidogrel in Zucker Diabetic Fatty Rats due to Impaired Clopidogrel Inactivation by Carboxylesterase 1 and Increased Exposure to Active Metabolite","volume":"47","author":"Yao","year":"2019","journal-title":"Drug Metab. Dispos."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2020.114142_b0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000441230","article-title":"Metabolic Interaction Potential between Clopidogrel and Sulfonylurea Antidiabetic Agents: Effects on Clopidogrel Bioactivation","volume":"97","author":"Shao","year":"2016","journal-title":"Pharmacology"},{"key":"10.1016\/j.bcp.2020.114142_b0080","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1475-2840-12-136","article-title":"Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin","volume":"12","author":"Mansor","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.bcp.2020.114142_b0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1463-1326.2004.00392.x","article-title":"Development and application of rodent models for type 2 diabetes","volume":"7","author":"Chen","year":"2005","journal-title":"Diabetes Obes. Metab."},{"issue":"11","key":"10.1016\/j.bcp.2020.114142_b0090","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1053\/meta.2000.17721","article-title":"A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat","volume":"49","author":"Reed","year":"2000","journal-title":"Metabolism"},{"issue":"2\u20133","key":"10.1016\/j.bcp.2020.114142_b0095","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejps.2008.10.013","article-title":"Segmental-dependent membrane permeability along the intestine following oral drug administration: Evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat","volume":"36","author":"Dahan","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4\u20135","key":"10.1016\/j.bcp.2020.114142_b0100","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ejps.2012.12.025","article-title":"Lamivudine permeability study: a comparison between PAMPA, ex vivo and in situ Single-Pass Intestinal Perfusion (SPIP) in rat jejunum","volume":"48","author":"Reis","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2020.114142_b0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0929-6646(08)60006-6","article-title":"Application of rat in situ single-pass intestinal perfusion in the evaluation of presystemic extraction of indinavir under different perfusion rates","volume":"107","author":"Ho","year":"2008","journal-title":"J. Formos Med. Assoc."},{"issue":"24","key":"10.1016\/j.bcp.2020.114142_b0110","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.jacc.2008.07.068","article-title":"Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo","volume":"52","author":"Erlinge","year":"2008","journal-title":"J Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.bcp.2020.114142_b0115","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/2042098611422559","article-title":"Metabolic activation of clopidogrel: in vitro data provide conflicting evidence for the contributions of CYP2C19 and PON1","volume":"2","author":"Polasek","year":"2011","journal-title":"Ther. Adv. Drug Saf."},{"issue":"1","key":"10.1016\/j.bcp.2020.114142_b0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0092-8674(00)80900-9","article-title":"An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway","volume":"92","author":"Kliewer","year":"1998","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bcp.2020.114142_b0125","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF03261926","article-title":"Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs","volume":"51","author":"Dostalek","year":"2012","journal-title":"Clin. Pharmacokinet."},{"issue":"23\u201324","key":"10.1016\/j.bcp.2020.114142_b0130","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.lfs.2011.08.019","article-title":"Altered intestinal P-glycoprotein expression levels in a monosodium glutamate-induced obese mouse model","volume":"89","author":"Nawa","year":"2011","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bcp.2020.114142_b0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1515\/dmdi-2013-0036","article-title":"Pregnane X receptor (PXR)\u2013a contributor to the diabetes epidemic?","volume":"29","author":"Hukkanen","year":"2014","journal-title":"Drug Metabol. Drug Interact."},{"issue":"6","key":"10.1016\/j.bcp.2020.114142_b0140","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.2337\/db12-1039","article-title":"PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice","volume":"62","author":"He","year":"2013","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.bcp.2020.114142_b0145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.diabet.2016.04.004","article-title":"Impact of gut microbiota on diabetes mellitus","volume":"42","author":"Blandino","year":"2016","journal-title":"Diabetes Metab."},{"issue":"12","key":"10.1016\/j.bcp.2020.114142_b0150","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1021\/acs.molpharmaceut.8b00875","article-title":"Gut Microbiota-Mediated Bile Acid Transformations Alter the Cellular Response to Multidrug Resistant Transporter Substrates in Vitro: Focus on P-glycoprotein","volume":"15","author":"Enright","year":"2018","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.bcp.2020.114142_b0155","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.immuni.2014.06.014","article-title":"Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4","volume":"41","author":"Venkatesh","year":"2014","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.bcp.2020.114142_b0160","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/1753-0407.12771","article-title":"Plasma bile acid changes in type 2 diabetes correlated with insulin secretion in two-step hyperglycemic clamp","volume":"10","author":"Wang","year":"2018","journal-title":"J. Diabetes"},{"issue":"6","key":"10.1016\/j.bcp.2020.114142_b0165","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1073\/pnas.051551698","article-title":"The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity","volume":"98","author":"Staudinger","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"3","key":"10.1016\/j.bcp.2020.114142_b0170","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1073\/pnas.0336235100","article-title":"Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance","volume":"100","author":"Dussault","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.bcp.2020.114142_b0175","doi-asserted-by":"crossref","first-page":"46751","DOI":"10.1038\/srep46751","article-title":"Glucose-dependent regulation of pregnane X receptor is modulated by AMP-activated protein kinase","volume":"7","author":"Oladimeji","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2020.114142_b0180","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1124\/jpet.106.110577","article-title":"Antiplatelet agents aspirin and clopidogrel are hydrolyzed by distinct carboxylesterases, and clopidogrel is transesterificated in the presence of ethyl alcohol","volume":"319","author":"Tang","year":"2006","journal-title":"J Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2020.114142_b0185","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/molecules13020412","article-title":"Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs","volume":"13","author":"Hosokawa","year":"2008","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.bcp.2020.114142_b0190","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/138920010794328904","article-title":"The role of intestinal carboxylesterase in the oral absorption of prodrugs","volume":"11","author":"Imai","year":"2010","journal-title":"Curr. Drug. Metab."},{"issue":"11","key":"10.1016\/j.bcp.2020.114142_b0195","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.lfs.2007.07.026","article-title":"Carboxylesterase in the liver and small intestine of experimental animals and human","volume":"81","author":"Taketani","year":"2007","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.bcp.2020.114142_b0200","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1124\/dmd.31.12.1520","article-title":"The small intestine as a xenobiotic-metabolizing organ","volume":"31","author":"Kaminsky","year":"2003","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.bcp.2020.114142_b0205","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF03190865","article-title":"Expression of genes encoding for drug metabolising cytochrome P450 enzymes and P-glycoprotein in the rat small intestine; comparison to the liver","volume":"28","author":"Lindell","year":"2003","journal-title":"Eur. J. Drug. Metab. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.bcp.2020.114142_b0210","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s11095-013-1158-5","article-title":"Contributions of intestine and plasma to the presystemic bioconversion of vicagrel, an acetate of clopidogrel","volume":"31","author":"Qiu","year":"2014","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.bcp.2020.114142_b0215","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1124\/dmd.116.071092","article-title":"Evaluation of Clopidogrel Conjugation Metabolism: PK Studies in Man and Mice of Clopidogrel Acyl Glucuronide","volume":"44","author":"Savu","year":"2016","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.bcp.2020.114142_b0220","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0006-2952(92)90445-O","article-title":"Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel","volume":"44","author":"Savi","year":"1992","journal-title":"Biochem. Pharmacol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220303786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220303786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:16:52Z","timestamp":1757769412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220303786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":44,"alternative-id":["S0006295220303786"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114142","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2 diabetes mellitus decreases systemic exposure of clopidogrel active metabolite through upregulation of P-glycoprotein in rats","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114142"}}